Simultaneous quantification of total eicosapentaenoic acid, docosahexaenoic acid and arachidonic acid in plasma by high-performance liquid chromatography-tandem mass spectrometry

Biomedical Chromatography

Volumn 25, Issue 6, 2011, Pages 652-659

  Salm, Paul ^a   Taylor, Paul J ^a   Kostner, Karam ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b MATER HOSPITAL   (Australia)

Author keywords

Arachidonic acid; Docosahexaenoic acid; Eicosapentaenoic acid; HPLC; Mass spectrometry; Omega 3 fatty acids

Indexed keywords

ASCORBIC ACID; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; POLYUNSATURATED FATTY ACIDS;

ARACHIDONIC ACIDS; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; HPLC; HPLC-MS-MS; HUMAN PLASMAS; OMEGA-3-FATTY ACIDS; TANDEM MASS SPECTROMETRY; TANDEM-MASS SPECTROMETRY;

MASS SPECTROMETRY;

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ACCURACY; ARTICLE; FATTY ACID BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; LIPID BLOOD LEVEL; LIQUID LIQUID EXTRACTION; MALE; NORMAL HUMAN; PLASMA; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

EID: 79955779740     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1496     Document Type: Article

References (35)

1. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC and Ma J. Blood levels of long chain n-3 fatty acids and the risk of sudden death. New England Journal of Medicine 2002; 346: 1113-1118.
2. Arab L. Biomarkers of fat and fatty acid intake. Journal of Nutrition 2003; 133: 925S-932S.
3. Aveldaño MI and Horrocks LA. Quantitative release of fatty acids from lipids by a simple hydrolysis procedure. Journal of Lipid Research 1983; 24: 1101-1105.
4. Brown AJ, Roberts DCK, Pritchard JE and Truswell AS. A mixed Australian fish diet and fish oil supplementation: impact on the plasma lipid profile of healthy men. American Journal of Clinical Nutrition 1990; 52: 825-833.
5. Bryhn M, Hansteen H, Schanche T and Aakre SE. The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters. Prostaglandins, Leukotrienes and Essential Fatty Acids 2006; 75: 19-24.
6. Cao J, Schwichtenberg KA, Hanson NQ and Tsai MY. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clinical Chemistry 2006; 52: 2265-2272.
7. Chung T-C, Kou H-S, Chao M-C, Ou Y-J and Wu H-L. A simple and sensitive liquid chromatographic method for the analysis of free docosanoic, tetracosanoic and hexacosanoic acids in human plasma as fluorescent derivatives. Analytica Chimica Acta 2008; 611: 113-118.
8. Donadio Jr JV, Larson TS, Bergstralh EJ, Grande JP. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy. Journal of the American Society of Nephrology 2001; 12: 791-799.
9. Duffin K, Obukowicz M, Raz A and Shieh JJ. Electrospray/tandem mass spectrometry for quantitative analysis of lipid remodelling in essential fatty acid deficient mice. Analytical Biochemistry 2000; 279: 179-188.
10. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico, Lancet 1999; 354: 447-455.
11. Harris WS and von Schacky C. The Omega-3 index: a new risk factor for death from coronary heart disease? Preventative Medicine 2004; 39: 212-220.
12. Karlsson AA, Michelsen P, Larsen A and Odham G. Normal-phase liquid chromatography class separation and species determination of phospholipids utilizing electrospray mass spectrometry/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 1996; 10: 775-780.
13. Kris-Etherton PM, Harris WS and Appel LJ. Fish consumption, fish oil, omega-3 fatty acids and cardiovascular disease. Circulation 2002; 106: 2747-2757.
14. Lagerstedt SA, Hinrichs DR, Batt SM, Magera MJ, Rinaldo P and McConnell JP. Quantitative determination of plasma C8-C26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Molecular Genetics and Metabolism 2001; 73: 38-45.
15. Lepage G and Roy CC. Improved recovery of fatty acid through direct transesterification without prior extraction or purification. Journal of Lipid Research 1984; 25: 1391-1396.
16. Lepage G and Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. Journal of Lipid Research 1986; 27: 114-120.
17. Mantzioris E, Cleland LG, Gibson RA, Neumann MA, Demasi M and James MJ. Biochemical effects of a diet containing foods enriched with n-3 fatty acids. American Journal of Clinical Nutrition 2000; 72: 42-48.
18. Marangoni F, Angeli MT, Colli S, Eligini S, Tremoli E, Sirtori CR and Galli C. Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout. Biochimica et Biophysica Acta 1993; 1210: 55-62.
19. Marchioli R, Avanzini F, Barzi F, Chieffo C, Di Castelnuovo A, Franzosi MG, Geraci E, Maggioni AP, Marfisi RM, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G and Valagussa F. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. European Heart Journal 2001; 22: 2085-2103.
20. Marchioli R, Barzi F, Bomba E, Chieffo C, Gregorio DD, Mascio RD, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F and on behalf of the GISSI-Prevenzione investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105: 1897-1903.
21. Masood A, Stark KD and Salem Jr N. A simplified and efficient method for the analysis of fatty acid methyl esters suitable for large clinical studies. Journal of Lipid Research 2005; 46: 2299-2305.
22. Matuszewski BK, Constanzer ML and Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Analytical Chemistry 2003; 75: 3019-3030.
23. Mauriala T, Herzig KH, Heinonen M, Idziak J and Auriola S. Determination of long-chain fatty acid acyl-coenzyme A compounds using liquid chromatography-electrospray ionization tandem mass spectrometry. Journal of Chromatography B 2004; 808: 263-268.
24. Morrison WR and Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. Journal of Lipid Research 1964; 5: 600-608.
25. Murphy RC, Barkley RM, Zemski Berry K, Hankin J, Harrison K, Johnson C, Krank J, McAnoy A, Uhlson C and Zarini S. Electrospray ionization and tandem mass spectrometry of eicosanoids. Analytical Biochemistry 2005; 346: 1-42.
26. Pacetti D, Boselli E, Hulan HW and Frega NG. High performance liquid chromatography-tandem mass spectrometry of phospholipid molecular species in eggs from hens fed diets enriched in seal blubber oil. Journal of Chromatography A 2005; 1097: 66-73.
27. Paganelli F, Maixent J-M, Duran M-J, Parhizgar R, Pieroni G and Sennoune S. Altered erythrocyte n-3 fatty acids in Mediterranean patients with coronary artery disease. International Journal of Cardiology 2001; 78: 27-32.
28. Paik M-J, Lee K-O and Shin H-S. Determination of very-long-chain fatty acids in serum by gas chromatography-nitrogen-phosphorus detection following cyanomethylation. Journal of Chromatography B 1999; 721: 3-11.
29. Rodriguez-Ruiz J, Belarbi EH, Sanchez JLG and Alonso DL. Rapid simultaneous lipid extraction and transesterification for fatty acid analyses. Biotechnology Techniques 1998; 12: 689-691.
30. Rupp H, Wagner D, Rupp T, Schulte L-M and Maisch B. Risk stratification by the 'EPA+DHA level' and the 'EPA/AA ratio'. Herz 2004; 29: 673-685.
31. Salem N, Reyzer M and Karanian J. Losses of arachidonic acid in rat liver after alcohol inhalation. Lipids 1996; 31: 153-156.
32. Siscovick DS, Raghunathan TE, King I, Weinmann S, Bovbjerg VE, Kushi L, Cobb LA, Copass MK, Psaty BM, Lemaitre R, Retzlaff B and Knopp RH. Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. American Journal of Clinical Nutrition 2000; 71: 208S-212S.
33. Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, Gallagher PJ, Calder PC and Grimble RF. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet 2003; 361: 477-485.
34. Valianpour F, Selhorst JM, van Lint LA, van Gennip AH, Wanders RA and Kemp S. Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry. Molecular Genetics and Metabolism 2003; 79: 189-196.
35. Zehethofer N, Pinto DM and Volmer DA. Plasma free fatty acid profiling in a fish oil human intervention study using ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2008; 22: 2125-2133.